As shown in Fig. 2d, in lung adenocarcinoma, there was no significant difference in the overall survival between patients with high FRα expression and those with low FRα expression (p = 0.1168, HR = 0.6773, 95% CI 0.4186–1.096). The gene discussed is FOLR1; the disease is lung adenocarcinoma.